These findings in the progression of ESCC disease indicate that STAT3 negatively regulates LHPP expression by binding to its promoter region, suggesting a significant transcriptional inhibitory role that contributes to the pathophysiology of the disease. The gene discussed is LHPP; the disease is esophageal squamous cell carcinoma.